Molecular pathways in sporadic PD

Parkinsonism and Related Disorders

Volumn 18, Issue SUPPL. 1, 2012, Pages

  Valente, Enza Maria ^a,b   Arena, Giuseppe ^a,c   Torosantucci, Liliana ^a   Gelmetti, Vania ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Alpha synuclein; Autophagy; Genetics; Mitochondria; Molecular pathways; Protein aggregates; Sporadic Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; BRAIN PROTEIN; DJ 1 PROTEIN; GLUCOSYLCERAMIDASE; GLUCOSYLCERAMIDE; LYSOSOME ENZYME; MITOCHONDRIAL DNA; PARKIN; PROTEIN PINK1; UBIQUITIN; UNCLASSIFIED DRUG;

AGING; ARTICLE; ATP13A2 GENE; AUTOPHAGY; AUTOSOMAL DOMINANT INHERITANCE; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GBA GENE; GENE; GENE MUTATION; GENE OVEREXPRESSION; GENETIC POLYMORPHISM; GENETIC RISK; HAPLOINSUFFICIENCY; HETEROZYGOSITY; HUMAN; LEWY BODY; MITOCHONDRIAL MEMBRANE POTENTIAL; MOLECULAR MECHANICS; NEUROPATHOLOGY; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FOLDING; SNCA GENE; SPORADIC PARKINSON DISEASE; UBIQUITINATION;

EID: 84858656297     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/s1353-8020(11)70023-2     Document Type: Article

References (25)

1. Lesage S, Brice A. Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet 2009;18:R48-59.
2. Lucking CB, Durr A, Bonifati V, Vaughan J, De Michele G, Gasser T, et al. Association between early-onset Parkinson's disease and mutations in the Parkin gene. N Engl J Med 2000;342:1560-7.
3. Sidransky E, Nalls MA, Aaslu JO, Aharon-Peretz J, Annesi G, Barbosa ER, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med 2009;361:1651-61.
4. Farrer MJ, Stone JT, Lin CH, Dachsel JC, Hulihan MM, Haugarvoll K, et al. Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia. Parkinsonism Relat Disord 2007;13:89-92.
5. Burbulla LF, Kruger R. Converging environmental and genetic pathways in the pathogenesis of Parkinson's disease. J Neurol Sci 2011;306:1-8.
6. Lin CH, Wu RM, Tai CH, Chen ML, Hu FC. Lrrk2 S1647T and BDNF V66M interact with environmental factors to increase risk of Parkinson's disease. Parkinsonism Relat Disord 2011;17:84-8.
7. Martin I, Dawson VL, Dawson TM. Recent advances in the genetics of Parkinson's disease. Annu Rev Genom Human Genet 2011;12:301-25.
8. Cookson MR, Bandmann O. Parkinson's disease: insights from pathways. Hum Mol Genet 2010;19:R1-27.
9. Bender A, Krishnan KJ, Morris CM, Taylor GA, Reeve AK, Perry RH, et al. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet 2006;38:515-7.
10. Tansey MG, Goldberg MS. Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis 2010;37:510-8.
11. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, et al. Alpha-Synuclein locus triplication causes Parkinson's disease. Science 2003;302:841.
12. Pihlstrøm L, Toft M. Genetic variability in SNCA and Parkinson's disease. Neurogenetics 2011 Jul 29 [Epub ahead of print]. doi: 10.1007/s10048-011-0292-7.
13. Venda LL, Cragg SJ, Buchman VL, Wade-Martins R. alpha-Synuclein and dopamine at the crossroads of Parkinson's disease. Trends Neurosci 2010;33: 559-68.
14. Angot E, Steiner JA, Hansen C, Li JY, Brundin P. Are synucleinopathies prion-like disorders? Lancet Neurol 2010;9:1128-38.
15. Schapira AH. Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol 2008;7:97-109.
16. Bueler H. Mitochondrial dynamics, cell death and the pathogenesis of Parkinson's disease. Apoptosis 2010;15:1336-53.
17. Shin JH, Ko HS, Kang H, Lee Y, Lee YI, Pletinkova O, et al. PARIS (ZNF746) repression of PGC-1alpha contributes to neurodegeneration in Parkinson's disease. Cell 2011;144:689-702.
18. Cookson MR. DJ-1, PINK1, and their effects on mitochondrial pathways. Mov Disord 2010;25(Suppl 1):S44-8.
19. Matsuda N, Tanaka K. Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease? J Alzheim Dis 2010;19:1-9.
20. Karbowski M, Youle RJ. Regulating mitochondrial outer membrane proteins by ubiquitination and proteasomal degradation. Curr Op Cell Biol 2011;23:476-82.
21. Vives-Bauza C, Przedborski S. Mitophagy: the latest problem for Parkinson's disease. Trends Mol Med 2011;17:158-65.
22. Michiorri S, Gelmetti V, Giarda E, Lombardi F, Romano F, Marongiu R, et al. The Parkinson-associated protein PINK1 interacts with Beclin1 and promotes autophagy. Cell Death Differ 2010;17:962-74.
23. McCoy MK, Cookson MR. DJ-1 regulation of mitochondrial function and autophagy through oxidative stress. Autophagy 2011;7:531-2.
24. Di Fonzo A, Chien HF, Socal M, Giraudo S, Tassorelli C, Iliceto G, et al. ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease. Neurology 2007;68:1557-62.
25. Mazzulli JR, Xu YH, Sun Y, Knight AL, McLean PJ, Caldwell GA, et al. Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 2011;146:37-52.